Grace Therapeutics, Inc. (GRCE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Grace Therapeutics, Inc., with annual and quarterly history.
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.05x | -2.88x | -1.74x | -0.53x | -1.88x | -0.38x |
| P/B Ratio | 1.20x | 0.41x | 0.36x | 0.33x | 0.17x | 0.13x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 37.95x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 61.2% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -8377.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -10039.8% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -4995.9% |
| Liquidity | ||||||
| Current Ratio | 8.10x | 11.77x | 14.26x | 8.59x | 13.97x | 39.50x |
| Quick Ratio | 8.10x | 11.77x | 14.26x | 8.59x | 13.97x | 39.50x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..